Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1969 1
1971 3
1972 5
1974 2
1975 1
1976 2
1977 2
1978 3
1979 5
1980 7
1981 6
1982 8
1983 7
1984 8
1985 9
1986 2
1987 8
1988 6
1989 6
1990 7
1991 7
1992 13
1993 9
1994 11
1995 8
1996 12
1997 5
1998 13
1999 6
2000 6
2001 5
2002 12
2003 13
2004 13
2005 12
2006 16
2007 15
2008 17
2009 27
2010 29
2011 22
2012 30
2013 20
2014 16
2015 23
2016 22
2017 29
2018 19
2019 26
2020 31
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

562 results
Results by year
Filters applied: . Clear all
Page 1
Pathways and mechanisms of venetoclax resistance.
Bose P, Gandhi V, Konopleva M. Bose P, et al. Among authors: gandhi v. Leuk Lymphoma. 2017 Sep;58(9):1-17. doi: 10.1080/10428194.2017.1283032. Epub 2017 Jan 31. Leuk Lymphoma. 2017. PMID: 28140720 Free PMC article. Review.
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W. Jain N, et al. Among authors: gandhi v. N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574. N Engl J Med. 2019. PMID: 31141631 Clinical Trial.
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma.
Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, Chen PH, Boroughs LK, Rodriguez MLM, Zhang W, Parlati F, Wang J, Gandhi V, Skoulidis F, DeBerardinis RJ, Minna JD, Heymach JV. Galan-Cobo A, et al. Among authors: gandhi v. Cancer Res. 2019 Jul 1;79(13):3251-3267. doi: 10.1158/0008-5472.CAN-18-3527. Epub 2019 Apr 30. Cancer Res. 2019. PMID: 31040157 Free PMC article.
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance.
Byers LA, Diao L, Wang J, Saintigny P, Girard L, Peyton M, Shen L, Fan Y, Giri U, Tumula PK, Nilsson MB, Gudikote J, Tran H, Cardnell RJ, Bearss DJ, Warner SL, Foulks JM, Kanner SB, Gandhi V, Krett N, Rosen ST, Kim ES, Herbst RS, Blumenschein GR, Lee JJ, Lippman SM, Ang KK, Mills GB, Hong WK, Weinstein JN, Wistuba II, Coombes KR, Minna JD, Heymach JV. Byers LA, et al. Among authors: gandhi v. Clin Cancer Res. 2013 Jan 1;19(1):279-90. doi: 10.1158/1078-0432.CCR-12-1558. Epub 2012 Oct 22. Clin Cancer Res. 2013. PMID: 23091115 Free PMC article.
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT.
Barker KL, Newman M, Stallard N, Leal J, Minns Lowe C, Javaid MK, Noufaily A, Adhikari A, Hughes T, Smith DJ, Gandhi V, Cooper C, Lamb SE. Barker KL, et al. Among authors: gandhi v. Health Technol Assess. 2019 Aug;23(44):1-318. doi: 10.3310/hta23440. Health Technol Assess. 2019. PMID: 31456562 Free PMC article. Clinical Trial.
Pulmonary Embolism.
Rali P, Gandhi V, Malik K. Rali P, et al. Among authors: gandhi v. Crit Care Nurs Q. 2016 Apr-Jun;39(2):131-8. doi: 10.1097/CNQ.0000000000000106. Crit Care Nurs Q. 2016. PMID: 26919674 Free article. Review.
Massive Hemoptysis.
Rali P, Gandhi V, Tariq C. Rali P, et al. Among authors: gandhi v. Crit Care Nurs Q. 2016 Apr-Jun;39(2):139-47. doi: 10.1097/CNQ.0000000000000107. Crit Care Nurs Q. 2016. PMID: 26919675 Review.
562 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page